스피로노락톤 관련 여성형 탈모

Q: Does 스피로노락톤 help with 여성형 탈모?

Based on 45 studies with 6,441 participants, there is strong evidence from multiple clinical trials that 스피로노락톤 may support 여성형 탈모 management. Our evidence grade is A (Strong Evidence).

Q: How much 스피로노락톤 should I take for 여성형 탈모?

Studies have used various dosages. A commonly studied range is 100-200 mg/day (prescription). Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of 스피로노락톤?

Reported side effects may include Menstrual irregularities, Breast tenderness, Hyperkalemia (elevated potassium levels), Dizziness and orthostatic hypotension. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for 스피로노락톤 and 여성형 탈모?

We rate the evidence as Grade A (Strong Evidence). This rating is based on 45 peer-reviewed studies with 6,441 total participants. The overall direction of effect is positive.

총 5,743명의 참여자를 대상으로 한 19건의 연구(메타분석 2건, RCT 4건)에 근거합니다. 19건 중 16건의 연구에서 긍정적인 효과가 나타났습니다.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dspironolactone\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

결론

Spironolactone is strongly supported by research as an effective option that may help women with female pattern hair loss, with both oral and topical formulations showing benefits in clinical trials.

84% of studies show positive effects, including 4 RCTs focused on women
Both oral and topical formulations have demonstrated benefits
A dedicated meta-analysis confirms efficacy and safety in female pattern hair loss
Combination with minoxidil may offer enhanced results

Key Study Findings

Review

Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.

Dose: None vs: None Outcome: None 효과: None None

대상 집단: women with androgenetic alopecia (female pattern hair loss)

Randomized Controlled Trial n=204 24 weeks Double-blind

Spironolactone versus Bicalutamide in female pattern hair loss: A randomised clinical trial.

Dose: Bicalutamide 50 mg/day; spironolactone 100 mg/day vs: Spironolactone 100 mg/day Outcome: Hair density and shaft diameter change at 24 … 효과: Frontal: +5.05 vs +3.13 hairs/cm2 (diff 1.92) P < 0.001 (frontal); P = 0.028

대상 집단: Women 18-50 with Sinclair Grade II-V FPHL (India)

randomized controlled trial n=80 24 weeks Single-blind

Evaluation of the Efficacy and Safety of Topical Spironolactone versus Topical Minoxidil in the Treatment …

Dose: Group A: 1% topical spironolactone gel twice daily; Group B: 5% topical minoxidil gel twice daily vs: Placebo 효과: Both groups showed statistically significant improvement. Group A: 10 mild, 16 moderate, 2 excellent None

RCT n=48 24 weeks Double-blind

Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a …

Dose: Spironolactone 100 mg once daily vs: Placebo 효과: Terminal hair counts: 9.48 vs 5.32 hairs/cm2; hair diameter: 4.23 vs 2.96 μm; moderate-to-marked imp p=0.063 (terminal hair counts)

Randomized Controlled Trial n=240 520 weeks Open-label

Nutritional deficiencies after sleeve gastrectomy and Roux-en-Y gastric bypass at 10 years: secondary analysis of …

Dose: None vs: Laparoscopic Roux-en-Y gastric bypass (LRYGB) Outcome: Nutritional deficiency prevalence at 10 years 효과: Iron deficiency: LSG 14% vs LRYGB 41% p=0.017 (iron deficiency)

대상 집단: Severely obese adults undergoing bariatric surgery

Review

Male and female pattern hair loss.

Dose: None vs: Placebo 효과: None None

Key Statistics

연구

6441

참여자

↑

Positive

등급

Referenced Papers

Spironolactone versus Bicalutamide in female pattern hair loss: A randomised clinical trial. Other

Clinical and experimental … 2026

Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments. Review

American journal of … 2026

Nutritional deficiencies after sleeve gastrectomy and Roux-en-Y gastric bypass at 10 years: secondary analysis of the SLEEVEPASS randomized clinical trial. RCT

The British journal … 2025 10 인용

Spironolactone reduces the risk of low-dose oral minoxidil-induced edema in women with female pattern hair loss. Other

Journal of the … 2025 3 인용

Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot … Other

International journal of … 2025 3 인용

Male and female pattern hair loss. Review

Australian prescriber 2025 2 인용

Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment. Other

Dermatology practical & … 2025 1 인용

Evaluation of the Efficacy and Safety of Topical Spironolactone versus Topical Minoxidil in the Treatment of Female Pattern Hair Loss: … Other

International journal of … 2025

Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs. Other

Frontiers in veterinary … 2024 15 인용

The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral … RCT

Journal of cosmetic … 2024 14 인용

Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies. Review

Journal of clinical … 2024 11 인용

Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study. Other

The Australasian journal … 2024 5 인용

Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management. Other

Archives of dermatological … 2024 4 인용

Inter-strain variability in responses to a single administration of the cannabidiol-rich cannabis extract in mice. Other

Food and chemical … 2024 1 인용

Improving efficacy and maintaining safety in the treatment of alopecia with low-dose oral minoxidil and spironolactone combination therapy: A retrospective … Other

JAAD international 2024 1 인용

The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis. Review

Cureus 2023 13 인용

Combination therapy in female pattern hair loss. Review

Journal of cosmetic … 2023 3 인용

Chronic Effects of Effective Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure and Vascular Outcomes in Treated and Untreated Hypertension … Other

Journal of personalized … 2022 16 인용

Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: … Case Report

Frontiers in medicine 2022 14 인용

Primary care provider attitudes, experiences and practices about cannabidiol (CBD) and barriers to patient-provider communication about CBD use: A qualitative … Other

PEC innovation 2022 11 인용

Spironolactone for treatment of female pattern hair loss. Other

Journal of the … 2020 43 인용

Spironolactone in dermatology: uses in acne and beyond. Review

Clinical and experimental … 2020 20 인용

Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind … Other

Dermatology practical & … 2020 10 인용

Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. Meta-Analysis

The Journal of … 2019 101 인용

Androgens in women: Androgen-mediated skin disease and patient evaluation. Review

Journal of the … 2019 95 인용

Androgens in women: Hormone-modulating therapies for skin disease. Review

Journal of the … 2019 55 인용

Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies. Review

Breast cancer research … 2019 36 인용

Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow. Other

Polski merkuriusz lekarski … 2019 4 인용

Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Observational

International journal of … 2018 142 인용

Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. Review

International journal of … 2018 129 인용

Female pattern hair loss. Other

Australian journal of … 2018 8 인용

Interventions for female pattern hair loss. Meta-Analysis

The Cochrane database … 2016 18 인용

Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis. Review

The Medical clinics … 2015 66 인용

Evidence-based approach to cutaneous hyperandrogenism in women. Review

Journal of the … 2015 50 인용

Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy. Other

Journal of the … 2015 43 인용

Hair loss in women. Review

Clinical obstetrics and … 2015 9 인용

Female pattern hair loss. Review

Current problems in … 2015 8 인용

[Spironolactone in dermatological treatment. On and off label indications]. Other

Der Hautarzt; Zeitschrift … 2013 19 인용

Female pattern alopecia: current perspectives. Review

International journal of … 2013

Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. Review

The British journal … 2011 96 인용

Treatment of female pattern hair loss with the androgen receptor antagonist flutamide. Case Report

The Australasian journal … 2011 44 인용

Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. Other

Dermatologic clinics 2010 80 인용

Use of spironolactone in dermatology. Review

Skinmed 2010 33 인용

Successful treatment of female-pattern hair loss with spironolactone in a 9-year-old girl. Case Report

The Australasian journal … 2009 31 인용

Hair loss in women. Review

Seminars in cutaneous … 2009 4 인용

Treating female pattern hair loss. Noticeable hair loss can be deeply distressing. Here are some medical treatments that may help. Other

Harvard women's health … 2009

A review of hormonal therapy for female pattern (androgenic) alopecia. Review

Dermatology online journal 2008

Treatment of female pattern hair loss with a combination of spironolactone and minoxidil. Case Report

The Australasian journal … 2007 32 인용

[The treatment of female pattern hair loss]. Review

Duodecim; laaketieteellinen aikakauskirja 2006

Evaluation and treatment of male and female pattern hair loss. Other

Journal of the … 2005 247 인용

Treatment of female pattern hair loss with oral antiandrogens. Other

The British journal … 2005 205 인용

Chronic telogen effluvium: a study of 5 patients over 7 years. Case Report

Journal of the … 2005 64 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

hairloss:: 100-200 mg/day (prescription)

상한량: 200 mg/day (hair loss indication)

연구에서 사용된 용량

용량	기간	효과	N
None	--	Neutral	--
Bicalutamide 50 mg/day; spironolactone 100 mg/day	24 weeks	Positive	204
Group A: 1% topical spironolactone gel twice daily; Group B: 5% topical minoxidil gel twice daily	24 weeks	Positive	80
Spironolactone 100 mg once daily	24 weeks	Positive	48
None	520 weeks	Positive	240
None	--	Positive	--
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi	16 weeks	Positive	45
4 g	--	Neutral	--

권장 복용 시간: Once or twice daily with food; prescription required

Safety & Side Effects

보고된 부작용

⚠ Menstrual irregularities
⚠ Breast tenderness
⚠ Hyperkalemia (elevated potassium levels)
⚠ Dizziness and orthostatic hypotension
⚠ Frequent urination

알려진 상호작용

● ACE inhibitors and ARBs (increased hyperkalemia risk)
● Potassium supplements and potassium-sparing diuretics (dangerous hyperkalemia)
● NSAIDs (may reduce diuretic effectiveness and increase kidney risk)
● Digoxin (spironolactone may increase digoxin levels)

일일 최대 섭취 허용량: 200 mg/day (hair loss indication)

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 스피로노락톤 help with 여성형 탈모?

Based on 45 studies with 6,441 participants, there is strong evidence from multiple clinical trials that 스피로노락톤 may support 여성형 탈모 management. Our evidence grade is A (Strong Evidence).

How much 스피로노락톤 should I take for 여성형 탈모?

Studies have used various dosages. A commonly studied range is 100-200 mg/day (prescription). Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of 스피로노락톤?

Reported side effects may include Menstrual irregularities, Breast tenderness, Hyperkalemia (elevated potassium levels), Dizziness and orthostatic hypotension. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for 스피로노락톤 and 여성형 탈모?

We rate the evidence as Grade A (Strong Evidence). This rating is based on 45 peer-reviewed studies with 6,441 total participants. The overall direction of effect is positive.

Related Evidence

스피로노락톤 다른 건강 상태에 대한 근거

안드로겐성 탈모 A

한눈에 보기

총 5,743명의 참여자를 대상으로 한 19건의 연구(메타분석 2건, RCT 4건)에 근거합니다. 19건 중 16건의 연구에서 긍정적인 효과가 나타났습니다.

Evidence Strength92%

High confidence

연구 분석

RCT (2)Meta (2)Other (41)

대안 비교

이 건강 상태에 대한 다른 성분의 비교 결과를 확인하세요.

모든 성분 보기: 여성형 탈모

자세히 알아보기

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.